Company profile: Evotec
1.1 - Company Overview
Company description
- Provider of drug discovery and gene therapy solutions, delivering CRO/CDMO services from initial research to clinical trials; AI-powered PanOmics and iPSC technologies for disease understanding in small molecules and biotherapeutics; hit identification; J.POD continuous biomanufacturing for biologics; and a proprietary ion channel assay.
Products and services
- CRO/CDMO Services: Evotec delivers end-to-end contract research and manufacturing services spanning initial discovery research through clinical trials, supporting drug discovery and development workflows for partners
- J.POD Biomanufacturing: Evotec operates continuous biomanufacturing at its Toulouse, France J.POD facility, enabling flexible, scalable biologics production capacity tailored to evolving program needs
- PanOmics and iPSC Technologies: Evotec architects AI-powered platforms leveraging panomics and human iPSC technologies to elucidate disease biology and human relevance, focusing on small molecules and biotherapeutics
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Evotec
EAG Laboratories
HQ: United States
Website
- Description: Provider of global scientific services across technology-related industries, offering materials testing & analysis; advanced microscopy (SEM, TEM, STEM); chemical analysis; battery materials analysis; biomedical analysis; and compositional analysis & material identification. Through multidisciplinary expertise in life, materials and engineering sciences, helps companies innovate and improve products, ensure quality and safety, and protect intellectual property.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full EAG Laboratories company profile →
Acsel Health
HQ: United States
Website
- Description: Provider of consulting services for the life sciences industry, ensuring patient access to life-saving medicines and helping life-changing innovations and health technologies reach their full potential through critical stages from early development to market maturity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Acsel Health company profile →
Nivagen Pharmaceuticals
HQ: United States
Website
- Description: Provider of generic prescription drugs and over-the-counter healthcare products for the North American market, engaged in development, acquisition, and sales. Leverages global partnerships with FDA-approved manufacturers to deliver affordable, high-quality products, including Carbamazepine, Celecoxib, Chlorthalidone, and Diclofenac Sodium/Misoprostol.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nivagen Pharmaceuticals company profile →
Lindus Health
HQ: United Kingdom
Website
- Description: Provider of end-to-end clinical trial services for the life sciences sector, covering ethics/IRB submissions, trial monitoring, data management, biostatistics, regulatory and payor affairs; AI-assisted trial design; direct patient recruitment; a clinical software platform (EDC, eSource, CTMS); CDISC SDTM data delivery; site and feasibility capabilities; and patient concierge support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lindus Health company profile →
Vistin Pharma
HQ: Norway
Website
- Description: Provider of active pharmaceuticals and solid dosage forms focused on metformin, manufacturing and supplying metformin in various forms, including Metformin Hydrochloride (API) meeting purity and flow quality standards and Metformin Direct Compressible Premix for immediate-release tablet compression.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vistin Pharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Evotec
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Evotec
2.2 - Growth funds investing in similar companies to Evotec
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Evotec
4.2 - Public trading comparable groups for Evotec
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →